title: Close to home: a history of Yale and Lyme disease.
abstract: Yale scientists played a pivotal role in the discovery of Lyme disease and are credited as the first to recognize, name, characterize, and treat the affliction. Today, Lyme disease is the most commonly reported vector-borne illness in the United States, affecting approximately 20,000 people each year, with the incidence having doubled in the past 10 years [1]. Lyme disease is the result of a bacterial infection transmitted to humans through the bite of an infected deer tick, which typically results in a skin rash at the site of attack. While most cases, when caught early, are easily treated by antibiotic therapy, delayed treatment can lead to serious systemic side effects involving the joints, heart, and central nervous system. Here we review Yale's role in the discovery and initial characterization of Lyme disease and how those early discoveries are crucial to our current understanding of the disease.
authors.affiliation: Department of Molecular Biophysics & Biochemistry, Yale University, New Haven, Connecticut, USA. shana.elbaum@yale.edu
authors.forename: Shana
authors.initials: S
authors.lastname: Elbaum-Garfinkle
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003237:Connecticut; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D008193:Lyme Disease / Q000175:diagnosis / Q000188:drug therapy / Q000266:history*; D014481:United States; D014495:Universities / Q000266:history
chemical_list: D000900:Anti-Bacterial Agents